Explore

Rapid Read Rapid Read
Genomic Study of North American Bison Aims to Enhance Conservation Efforts

Genomic Study of North American Bison Aims to Enhance Conservation Efforts

Researchers at the University of California, Santa Cruz, have utilized paleogenomics to create a genetic roadmap for the North American bison, aiming to guide conservation efforts. The study, published in Science, reveals the genetic history of bison, which once numbered in the tens of millions but were reduced to a few hundred due to human activity in the early 20th century. The research team sequenced the genomes of 160 bison, including ancient specimens, to establish a genetic baseline for healthy bison diversity. This baseline is crucial for genome-matched breeding programs aimed at restoring bison populations. The study also addresses misconceptions about cattle ancestry in bison, finding minimal cattle genetic influence in modern bison.
Rapid Read Rapid Read
Study Reveals Neanderthal DNA's Impact on Muscle Mass in Modern Humans

Study Reveals Neanderthal DNA's Impact on Muscle Mass in Modern Humans

A recent study has identified a Neanderthal version of a gene that enhances the body's response to growth hormone, resulting in increased muscle mass in adults who carry it. This genetic variant, inherited through interbreeding between modern humans and Neanderthals approximately 47,000 years ago, is still present in millions of people today. The research, led by Hugo Zeberg of Sweden's Karolinska Institutet and Philipp Kanis of Germany's Max Planck Institute for Evolutionary Anthropology, found that cells with the Neanderthal receptor grew 40% more than those with the modern human version. The study also noted that adults carrying this variant have, on average, about 270 grams more muscle mass than non-carriers. The effect of this gene variant appears to manifest around puberty, coinciding with a rise in growth hormone levels.
Rapid Read Rapid Read
Cross-Ancestry Polygenic Risk Scores Enhance Alzheimer's Risk Prediction

Cross-Ancestry Polygenic Risk Scores Enhance Alzheimer's Risk Prediction

A recent study has demonstrated that cross-ancestry polygenic risk scores (PRS) can improve the prediction of Alzheimer's disease (AD) risk in multiethnic cohorts. The research highlights the limitations of current PRS models, which are predominantly based on European ancestry data, leading to reduced predictive accuracy in non-European populations. By incorporating genetic data from diverse ancestries, the study found that cross-ancestry PRS models offer better risk stratification and capture early disease-related processes. This approach addresses the disparities in AD risk prediction and emphasizes the need for more inclusive genetic research.
Rapid Read Rapid Read
Neanderthal Growth Hormone Receptor Linked to Increased Muscle Mass in Modern Humans

Neanderthal Growth Hormone Receptor Linked to Increased Muscle Mass in Modern Humans

A study led by researchers from the Max Planck Institute for Evolutionary Anthropology and Karolinska Institutet has found that a Neanderthal-derived growth hormone receptor can increase muscle mass in modern humans. The receptor, which has two key changes absent in modern humans, leads to a stronger response to growth hormone. This variant is prevalent in South and East Asian populations, with up to 24% of people in some South Asian groups carrying it. The study found that adults with this receptor variant have, on average, 270 grams more muscle mass. The effect of this receptor becomes noticeable after childhood, suggesting its influence emerges during puberty.
Rapid Read Rapid Read
NIH Study Reveals Midlife Brain Immune Shift Linked to Aging and Alzheimer's

NIH Study Reveals Midlife Brain Immune Shift Linked to Aging and Alzheimer's

A study funded by the National Institutes of Health (NIH) has discovered a significant shift in the immune environment of the hippocampus, a brain region crucial for learning and memory. This shift begins around age 50 and may contribute to the persistent brain inflammation seen in neurodegenerative diseases like Alzheimer's. Researchers found that microglia, the brain's primary immune cells, decline from age 50 to 75, replaced by cells with stronger inflammatory signals. The study utilized advanced single-cell methods to analyze postmortem hippocampal tissue, revealing changes in immune cell identity and origin that were previously hidden.
Rapid Read Rapid Read
Scientists Identify 'Skinny Gene' Variant Offering Potential for Future Weight Loss Therapies

Scientists Identify 'Skinny Gene' Variant Offering Potential for Future Weight Loss Therapies

Researchers have discovered a genetic mutation, referred to as the 'skinny gene', that allows about one in 7,000 people to maintain a lean physique naturally. This mutation affects the FNIP1 gene, which when turned off, increases calorie burning rather than storing it. The study, published in Nature, involved genetic data from over a million people across three continents. Those with the mutation tend to have lower body fat and cholesterol, and a reduced risk of several diseases, including heart attack and stroke. The findings suggest potential for developing new drug therapies that could mimic these effects in the general population.
Rapid Read Rapid Read
Kriya Therapeutics Reports Success in Extending Lifespan with Gene Therapy in Mice

Kriya Therapeutics Reports Success in Extending Lifespan with Gene Therapy in Mice

Kriya Therapeutics has published preclinical data showing that a single administration of AAV-FGF21 gene therapy extended the lifespan and health span of aged mice. The therapy improved metabolic functions, preserved organ health, and maintained muscle strength and memory. These findings suggest that FGF21 gene therapy could be a promising strategy for promoting healthy aging and treating metabolic disorders. The study, led by Professor Fátima Bosch, highlights the potential of gene therapy to address age-related diseases and improve quality of life.
Rapid Read Rapid Read
Study Reveals Genetics Alone Do Not Explain SuperAgers' Cognitive Abilities

Study Reveals Genetics Alone Do Not Explain SuperAgers' Cognitive Abilities

A recent study published in Alzheimer's Research & Therapy has challenged the notion that SuperAgers, individuals in their 80s and 90s with exceptional memory abilities, owe their cognitive resilience to genetic factors alone. Researchers from the Healthy Aging & Alzheimer’s Research Care (HAARC) Center and the Translational Genomics Research Institute (TGen) examined 142 SuperAgers and 89 cognitively average older adults. They focused on the APOE gene and polygenic risk scores, which are known to influence Alzheimer's disease risk. The study found no significant difference in these genetic markers between SuperAgers and their peers, suggesting that genetics alone do not account for their superior memory retention. This research indicates that other factors, such as biological, environmental, and experiential pathways, may play a crucial role in maintaining cognitive health.
Reuters Reuters
Sweeping Russia energy sanctions head toward US Senate passage

Sweeping Russia energy sanctions head toward US Senate passage

By Patricia Zengerle WASHINGTON, Aug 7 (Reuters) - A large majority of the U.S.
Rapid Read Rapid Read
CAMP4 Therapeutics Initiates Human Trials for SYNGAP1 Rare Disease Treatment

CAMP4 Therapeutics Initiates Human Trials for SYNGAP1 Rare Disease Treatment

CAMP4 Therapeutics has received approval from Australia's drug regulator to begin clinical trials for a treatment targeting SYNGAP1-related disorders, a rare genetic condition characterized by epilepsy and neurodevelopmental delays. This trial marks the first human use of the antisense oligonucleotide (ASO) therapy, aiming to assess its safety, efficacy, and dosing. SYNGAP1 mutations are linked to significant intellectual disabilities, and the trial represents a critical step in addressing the unmet medical needs of affected patients.
Reuters Reuters
Armenian church leader accused of spy links amid Russia tensions to go on trial

Armenian church leader accused of spy links amid Russia tensions to go on trial

By Lucy Papachristou Aug 7 (Reuters) - Armenia will put the head of its ancient Apostolic Church and six senior clerics on trial on Friday, the latest move in a standoff with the government which accuses the church leader of links to foreign spies.
Rapid Read Rapid Read
New Insights into Cornelia de Lange Syndrome Highlight Genetic and Phenotypic Diversity

New Insights into Cornelia de Lange Syndrome Highlight Genetic and Phenotypic Diversity

Cornelia de Lange Syndrome (CdLS) is a rare neurodevelopmental disorder characterized by a range of physical and cognitive impairments. Recent research has expanded the understanding of the genetic and phenotypic diversity associated with CdLS. Advances in genomic technologies have identified various genes linked to the syndrome, such as NIPBL, SMC1A, and HDAC8. However, significant gaps remain in fully defining the condition's spectrum, complicating diagnosis and treatment. The research aims to integrate genetic and phenotypic data to improve diagnostic strategies and develop precision medicine approaches. This includes exploring genotype-phenotype relationships and potential therapeutic targets.